Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended-release Naltrexone (Vivitrol) for the Treatment of Alcohol Dependence in Urban Primary Care: a Feasibility Study

NCT00620750 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00620750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00620750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended-release Naltrexone (Vivitrol) for the Treatment of Alcohol Dependence in Urban Primary Care: a Feasibility Study
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
February 28, 2010
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence